# OnCo record loki-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/loki-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "loki-therapeutics" ;
  schema:name "Loki Therapeutics"@en ;
  schema:description "Loki Therapeutics uses weakened Listeria bacteria to deliver a piece of the tetanus vaccine into tumour cells, so that immune cells primed by childhood tetanus vaccination recognise and attack the tumour. Its first trial, with gemcitabine, is in pancreatic cancer that cannot be removed by surgery."@en ;
  schema:url <https://onco.cc/companies/loki-therapeutics/>, <https://www.lokitx.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.lokitx.com/>, <https://www.lokitx.com/science>, <https://clinicaltrials.gov/study/NCT07828236> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/bacterial-vector-vaccines/>, <https://onco.cc/technologies/engineered-bacteria-therapy/> .